Search

everythinglearnresearchcommunity

for

Search:↓

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Dianabol boosts muscle growth but has serious health risks and legal issues.

Urologists should screen for mental health issues before and during finasteride treatment.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Finasteride may cause slight depression and anxiety.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Psychotropic medications can cause skin problems but also treat some skin conditions.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Finasteride users have a very low risk of mental health issues, but those with hair loss may have slightly higher anxiety and depression.

Common skin conditions can greatly affect a person's mental health and social life.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Some herbal therapies may help with skin conditions, but more research is needed to confirm their safety and effectiveness.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Ayurvedic remedies may boost immunity and balance in cancer treatment but need more research.

The antidepressant escitalopram likely caused hair loss in a patient.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Brazilian keratin treatments can straighten hair but may contain harmful formaldehyde.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Post-finasteride syndrome's existence is uncertain; more research needed.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.